Tagayan, Nor-aiza U.
HRN: 01-70-80 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
AMPICILLIN 1GM (VIAL)
09/22/2025
09/24/2025
IVTT
2g
Q6hours
Thinly MSAF
Waiting Final Action
09/25/2025
CO-AMOXICLAV 625MG (TAB)
09/25/2025
10/01/2025
PO
625mg
BID
Sp 1 LTCS
Checking Initial Appropriateness
09/26/2025
MUPIROCIN 2%, 15G (TUBE)
09/26/2025
10/02/2025
TOPICAL
1ml
OD
SP CS
Waiting Final Action